Parameters | Number of patients | Percent (%) |
---|---|---|
Age at diagnosis, (Mean;range) | 36.1 ± 14.2 (28–55) | |
Baseline parity | ||
 Nulliparous | 14 | 31.8 |
 Pluriparous | 30 | 68.2 |
Presentation | ||
 Contact bleeding | 2 | 4.5 |
 Vaginal discharge | 1 | 2.3 |
 Asymptomatic | 41 | 93.2 |
Referral Cytology | ||
 ASCUS | 13 | 29.5 |
 AGC | 4 | 9.1 |
 LSIL | 8 | 18.2 |
 HSIL | 13 | 29.5 |
 AIS | 1 | 2.3 |
 NILM | 5 | 11.4 |
High-risk HPV | ||
 Negative | 4 | 9.1 |
 Positive | 39 | 88.6 |
 Unkonwn | 1 | 2.3 |
Height of LEEP specimens(cm; range) | 1.1 ± 0.2 (0.7–2) | |
Depth of LEEP specimens(cm; range) | 1.5 ± 0.3 (1–2) | |
Status of LEEP margin | ||
 Negative | 33 | 70.5 |
 Positive | 10 | 29.5 |
 Not evaluable | 1 | 2.3 |
AIS detected by | ||
 Papanicolaou test | 1 | 2.3 |
 Punch biopsy | 12 | 27.3 |
 LEEP only | 31 | 70.5 |
Multifocality | ||
 Yes | 4 | 9.1 |
 No | 40 | 90.9 |
Coexisting squamous disease | ||
 CIN I | 5 | 11.4 |
 CIN II | 8 | 18.2 |
 CIN III | 25 | 54.5 |
Absent | 6 | 13.6 |
Follow-up (month;range) | 36.9 ± 18.7 (3–101) | |
Status at the last contact | ||
 Abnormal cytology | 1 | 2.3 |
 Positive high-risk HPV | 6 | 13.6 |
 Both positive | 1 | 2.3 |
 Both negative | 36 | 81.8 |